| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GT Biopharma, Inc. | Director | Option to purchase Common Stock | 500K | Jan 27, 2023 | Direct | ||
| CASI Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 346K | May 25, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GTBP | GT Biopharma, Inc. | Jan 27, 2023 | 1 | $0 | 4 | Feb 1, 2023 | Director |
| GTBP | GT Biopharma, Inc. | Jul 15, 2022 | 3 | $0 | 4 | Jul 19, 2022 | Director |
| CASI | CASI Pharmaceuticals, Inc. | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
| CASI | CASI Pharmaceuticals, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |
| GTBP | GT Biopharma, Inc. | Feb 16, 2021 | 1 | $0 | 4 | Feb 14, 2022 | Director |
| GTBP | GT Biopharma, Inc. | Jan 13, 2021 | 0 | $0 | 3 | Feb 14, 2022 | Director |